XML 24 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity
 9 Months Ended
Oct. 28, 2017
Stockholders' Equity Note [Abstract]  
Shareholders' Equity
Note 9
Shareholders’ Equity
 
The following tables set forth the changes in Caleres, Inc. shareholders’ equity and noncontrolling interests for the thirty-nine weeks ended October 28, 2017 and October 29, 2016:

($ thousands)
Caleres, Inc. Shareholders’ Equity

Noncontrolling Interests

Total Equity

Equity at January 28, 2017
$
613,117

$
1,369

$
614,486

Net earnings
66,884

47

66,931

Other comprehensive income
2,312

26

2,338

Dividends paid
(9,033
)
—

(9,033
)
Acquisition of treasury stock
(5,993
)
—

(5,993
)
Issuance of common stock under share-based plans, net
(2,477
)
—

(2,477
)
Cumulative-effect adjustment from adoption of ASU 2016-09
441

—

441

Share-based compensation expense
8,394

—

8,394

Equity at October 28, 2017
$
673,645

$
1,442

$
675,087

 
($ thousands)
Caleres, Inc. Shareholders’ Equity

Noncontrolling Interests

Total Equity

Equity at January 30, 2016
$
601,484

$
988

$
602,472

Net earnings
72,280

2

72,282

Other comprehensive income (loss)
(446
)
(37
)
(483
)
Dividends paid
(9,094
)
—

(9,094
)
Acquisition of treasury stock
(23,139
)
—

(23,139
)
Issuance of common stock under share-based plans, net
(4,205
)
—

(4,205
)
Excess tax benefit related to share-based plans
3,264

—

3,264

Share-based compensation expense
5,966

—

5,966

Equity at October 29, 2016
$
646,110

$
953

$
647,063



Accumulated Other Comprehensive Loss
The following table sets forth the changes in accumulated other comprehensive loss (OCL) by component for the periods ended October 28, 2017 and October 29, 2016:
($ thousands)
Foreign Currency Translation

Pension and Other Postretirement Transactions (1)

Derivative Financial Instrument Transactions (2)

Accumulated Other Comprehensive (Loss) Income

Balance July 29, 2017
$
1,472

$
(29,357
)
$
(166
)
$
(28,051
)
Other comprehensive (loss) income before reclassifications
(633
)
—

258

(375
)
Reclassifications:
 
 
 


Amounts reclassified from accumulated other comprehensive loss
—

615

(118
)
497

Tax (benefit) provision
—

(236
)
43

(193
)
Net reclassifications
—

379

(75
)
304

Other comprehensive (loss) income
(633
)
379

183

(71
)
Balance October 28, 2017
$
839

$
(28,978
)
$
17

$
(28,122
)
 
 
 
 
 
Balance July 30, 2016
$
606

$
(5,932
)
$
(49
)
$
(5,375
)
Other comprehensive loss before reclassifications
(545
)
—

(150
)
(695
)
Reclassifications:
 
 
 
 
Amounts reclassified from accumulated other comprehensive loss
—

(478
)
79

(399
)
Tax provision (benefit)
—

189

(30
)
159

Net reclassifications
—

(289
)
49

(240
)
Other comprehensive loss
(545
)
(289
)
(101
)
(935
)
Balance October 29, 2016
$
61

$
(6,221
)
$
(150
)
$
(6,310
)
 
 
 
 
 
Balance January 28, 2017
$
192

$
(30,084
)
$
(542
)
(30,434
)
Other comprehensive income before reclassifications
647

—

716

1,363

Reclassifications:
 
 
 


Amounts reclassified from accumulated other comprehensive loss
—

1,794

(235
)
1,559

Tax (benefit) provision
—

(688
)
78

(610
)
Net reclassifications
—

1,106

(157
)
949

Other comprehensive income
647

1,106

559

2,312

Balance October 28, 2017
$
839

$
(28,978
)
$
17

$
(28,122
)
 
 
 
 


Balance January 30, 2016
$
(900
)
$
(5,356
)
$
392

$
(5,864
)
Other comprehensive income (loss) before reclassifications
961

—

(789
)
172

Reclassifications:
 
 
 


Amounts reclassified from accumulated other comprehensive loss
—

(1,432
)
392

(1,040
)
Tax provision (benefit)
—

567

(145
)
422

Net reclassifications
—

(865
)
247

(618
)
Other comprehensive income (loss)
961

(865
)
(542
)
(446
)
Balance October 29, 2016
$
61

$
(6,221
)
$
(150
)
$
(6,310
)

(1)
Amounts reclassified are included in selling and administrative expenses. See Note 11 to the condensed consolidated financial statements for additional information related to pension and other postretirement benefits.
(2)
Amounts reclassified are included in net sales, costs of goods sold, selling and administrative expenses and interest expense. See Notes 12 and 13 to the condensed consolidated financial statements for additional information related to derivative financial instruments.